← Back to feed
Eastleigh Voice·June 25, 2026 at 3:36 AM

The World Health Organization (WHO) is set to launch a clinical trial in the Democratic Republic of the Congo (DRC) next week to assess the effectiveness of two antiviral treatments, MBP134 and remdesivir, in reducing mortality among patients infected with Bundibugyo virus disease. This initiative comes as reported cases of the disease exceed 1,000. The trial will evaluate the treatments both individually and in combination, with preparations now complete.

AI summary. Verify with the original source.

Ebolaclinical trialWHODRCantiviral treatments

Read full story at Eastleigh Voice

Listen

Audio summaries is a Premium feature

Unlock audio summaries, audio summaries, AI chat, Wikipedia facts, and ad-free reading.

$3.99 / month · cancel anytime

Go Premium

Background facts

Wikipedia facts is a Premium feature

Unlock wikipedia facts, audio summaries, AI chat, Wikipedia facts, and ad-free reading.

$3.99 / month · cancel anytime

Go Premium

Similar stories